Prosecution Insights
Last updated: May 29, 2026

Lonza Sales AG

12 pending office actions • 11 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Portfolio Summary

12
Total Pending OAs
9
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
2
Due this week
3
Due this month
3
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (2)Due ≤ 30 days (3)Due ≤ 60 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
7
Medium (58%)
0
Easy (0%)
5
Unknown (42%)

Rejection Statute Mix

BucketCases
§103 only7 (58%)
No statute on record5 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WHITE, DENNIS MICHAEL 1 57.4% +48.8%
FOLEY, SHANON A 1 73.7% +18.1%
BREWSTER, HAYDEN R 1 61.9% +48.4%
ROYCE, LIAM A 1 65.0% +21.8%
POPA, ILEANA 1 21.0% +14.9%
PATTERSON, SARAH COOPER 1 58.6% +56.4%
ALLEN, SARAH ELIZABETH 1 61.9% +44.4%
TRAN, CHRISTINA L 1 46.8% +51.2%
MEJIAS, SAMANTHA LEE 1 47.4% +62.5%
JUEDES, AMY E 1 44.5% +41.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18172176 PRODUCTION OF EXTRACELLULAR VESICLES IN SINGLE-CELL SUSPENSION USING CHEMICALLY-DEFINED CELL CULTURE MEDIA POPA, ILEANA 9d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18246301 PROCESS FOR PREPARING EXTRACELLULAR VESICLES BREWSTER, HAYDEN R 44d overdue
17634897 EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF MEJIAS, SAMANTHA LEE 3d overdue
17594401 METHODS OF TREATING TUBERCULOSIS JUEDES, AMY E 1d overdue
18246312 PROCESS FOR PREPARING EXTRACELLULAR VESICLES ROYCE, LIAM A 7d
17635322 EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 TRAN, CHRISTINA L 7d
18172176 PRODUCTION OF EXTRACELLULAR VESICLES IN SINGLE-CELL SUSPENSION USING CHEMICALLY-DEFINED CELL CULTURE MEDIA POPA, ILEANA 9d
17793629 CHOLESTEROL ASSAYS FOR QUANTIFYING EXTRACELLULAR VESICLES WHITE, DENNIS MICHAEL 20d
17763973 STING AGONIST COMPRISING EXOSOMES COMBINED WITH IL-12 DISPLAYING EXOSOMES FOR TREATING A TUMOUR PATTERSON, SARAH COOPER 34d

Top Art Units

Art UnitApps
1637 2
1758 1
1671 1
1779 1
1777 1
1633 1
1675 1
1618 1
1644 1
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17793629 CHOLESTEROL ASSAYS FOR QUANTIFYING EXTRACELLULAR VESICLES WHITE, DENNIS MICHAEL 1758 §103 Non-Final OA 20d Pending Sep 05, 2023
18246304 METHODS OF PRODUCING EXTRACELLULAR VESICLES FOLEY, SHANON A 1671 Other Non-Final OA 42d Pending Mar 22, 2023
18246301 PROCESS FOR PREPARING EXTRACELLULAR VESICLES BREWSTER, HAYDEN R 1779 §103 Non-Final OA 44d overdue Pending Mar 22, 2023
18246312 PROCESS FOR PREPARING EXTRACELLULAR VESICLES ROYCE, LIAM A 1777 §103 Non-Final OA 7d Pending Mar 22, 2023
18172176 PRODUCTION OF EXTRACELLULAR VESICLES IN SINGLE-CELL SUSPENSION USING CHEMICALLY-DEFINED CELL CULTURE MEDIA POPA, ILEANA 1633 §103 Final Rejection 9d Pending Feb 21, 2023
17763973 STING AGONIST COMPRISING EXOSOMES COMBINED WITH IL-12 DISPLAYING EXOSOMES FOR TREATING A TUMOUR PATTERSON, SARAH COOPER 1675 Other Final Rejection 34d Pending Mar 25, 2022
17635298 EXTRACELLULAR VESICLES WITH ANTISENSE OLIGONUCLEOTIDES TARGETING KRAS ALLEN, SARAH ELIZABETH 1637 §103 Non-Final OA 47d Pending Feb 14, 2022
17635322 EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 TRAN, CHRISTINA L 1637 §103 Non-Final OA 7d Pending Feb 14, 2022
17634897 EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF MEJIAS, SAMANTHA LEE 1618 §103 Non-Final OA 3d overdue Pending Feb 11, 2022
17594401 METHODS OF TREATING TUBERCULOSIS JUEDES, AMY E 1644 Other Non-Final OA 1d overdue Pending Oct 14, 2021
17441162 EXTRACELLULAR VESICLE CONJUGATES AND USES THEREOF ANTHOPOLOS, PETER 1611 Other Non-Final OA 17d overdue Pending Sep 20, 2021
17293833 ENGINEERED EXTRACELLULAR VESICLES AND USES THEREOF ESPINOSA, CLAUDIA EDILMA 1654 Other Non-Final OA 13d Pending May 13, 2021

Managing Lonza Sales AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month